Education background:
1987-1991 at xiamen university bachelor of cell biology
1991-1996 institute of biophysics, Chinese academy of sciences, biophysics, Dr
The baylor college of medicine, 1996-1999 the department of biochemistry, a postdoctoral fellow
1999-2001, the United States department of biochemistry, a postdoctoral fellow at university of Texas southwestern medical center

Working experience:
2001-2003 scientists Syrrx companies in the United States
2003-2005 American scientists at Texas a&m medical center
2005-2010, the United States department of physiology, university of Texas southwestern medical center/Howard hughes medical institute
Lecturer - secondary research experts - assistant professor
Since 2010 - life science research institute, zhejiang university professor
 

The honor:
Outstanding youth fund gainer in zhejiang province in 2010
In 2011 the ministry of education in the new century excellent talents to support plan
One thousand people in zhejiang province in 2011
 

New drug research:
During Syrrx company as a scientist in the United States, Dr Ye Sheng as diabetes drug design based on structure, one of the main participants in the design of selective double peptide protease inhibitors (SYR - 322) was one of the 4 already through clinical trials. The Japanese ministry has approved in June 2010 the new drugs (medicines Nesina) listed.